Check out the companies making headlines before the bell: Pfizer — The pharmaceutical stock added 1.8% on better-than-expected fourth-quarter results . Pfizer reported adjusted earnings of 63 cents per share on $17.76 billion in revenue. Analysts polled by LSEG estimated earnings of 47 cents per share on revenue of $17.36 billion. PepsiCo — Shares of…
U.S. President Donald Trump speaks about prescription drug prices during an appearance in the Brady Press Briefing Room at the White House in Washington, U.S., November 20, 2020. Carlos Barria | Reuters Pharmaceutical companies appear to be hopeful about their growth under a Trump administration, after former President Joe Biden took a hardline stance on…
A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023. George Frey | Reuters The Biden administration on Friday unveiled the next 15 prescription drugs that will be subject to price negotiations between manufacturers and Medicare, kicking off the second phase of a landmark process that aims…
Check out the companies making headlines in midday trading: Intel — The struggling chip stock bounced into year-end, rising 1.2%. Intel has plunged just over 60% in 2024, making the stock poised to see its worst year on record and be the second-worst performer in the S & P 500 . Nvidia — The artificial…
